Hypera SA 2024 SR
The report for 2024 highlights Hypera Pharma's growth in the Brazilian pharmaceutical market and its commitment to innovation, with R$560 million invested in R&D. Key achievements include the creation of a Governance and Sustainability Committee, inclusion in the S&P Global Sustainability Yearbook for the third consecutive year, and maintaining a "B" score from CDP. The company advanced its environmental goals, achieving a 32.27% reduction in Scope 1 emissions intensity compared to 2019 and recovering over 95% of industrial waste. Social initiatives featured the "Adopt a Spring" project and health task forces benefiting hundreds of families.
Company: Hypera SA
Sector: Manufacturing
Country: Brazil
Year: 2024
Type: SR
Pages: 31
Back to company
Hypera SA
Annual Sustainability Report
The report for 2024 highlights Hypera Pharma's growth in the Brazilian pharmaceutical market and its commitment to innovation, with R$560 million invested in R&D. Key achievements include the creation of a Governance and Sustainability Committee, inclusion in the S&P Global Sustainability Yearbook for the third consecutive year, and maintaining a "B" score from CDP. The company advanced its environmental goals, achieving a 32.27% reduction in Scope 1 emissions intensity compared to 2019 and recovering over 95% of industrial waste. Social initiatives featured the "Adopt a Spring" project and health task forces benefiting hundreds of families.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Renewable Energy
Water Consumption
Total Waste
Employees